Research Phase 3 AstraZeneca Coronavirus Vaccine Study Reopens at URMC Sep. 1, 2020 Facebook Twitter LinkedIn Email Skip breadcrumb URMC Home Newsroom News Phase 3 AstraZeneca Coronavirus Vaccine Study Reopens at URMC